Key Metrics
CiteScore 

3
Recommended pre-submission checks
Powered by 

Topics Covered on Cancer Drug Resistance
Cancer Drug Resistance Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | OAE Publishing |
Planning to publish in Cancer Drug Resistance ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Cancer Drug Resistance
Paired single cell analysis reveals chemotherapy resistance in osteosarcoma
- 21 Apr 2026
- Cancer Drug Resistance
Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications
- 21 Apr 2026
- Cancer Drug Resistance
Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance
- 21 Apr 2026
- Cancer Drug Resistance
Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption.
- 20 Mar 2026
- Cancer drug resistance (Alhambra, Calif.)
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer.
- 6 Mar 2026
- Cancer drug resistance (Alhambra, Calif.)
TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms.
- 25 Feb 2026
- Cancer drug resistance (Alhambra, Calif.)
Paired single cell analysis reveals chemotherapy resistance in osteosarcoma
- 21 Apr 2026
- Cancer Drug Resistance
Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications
- 21 Apr 2026
- Cancer Drug Resistance
Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance
- 21 Apr 2026
- Cancer Drug Resistance
Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption.
- 20 Mar 2026
- Cancer drug resistance (Alhambra, Calif.)
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer.
- 6 Mar 2026
- Cancer drug resistance (Alhambra, Calif.)
TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms.
- 25 Feb 2026
- Cancer drug resistance (Alhambra, Calif.)